Pharma & Biotech

The battle for dominance in the lucrative weight-loss medication sector has entered a critical new phase. Pharmaceutical giant Pfizer has...

Investor attention is firmly fixed on Assembly Biosciences as the biotechnology firm prepares to release its third-quarter financial results. Following...

Thermo Fisher Scientific, a global leader in life sciences, has announced a transformative $8.9 billion acquisition that underscores its ambitious...

The proposed acquisition of CureVac by BioNTech is accelerating toward its final stages. CureVac investors face a pivotal decision on...

Investors in the Mainz-based biotechnology firm BioNTech received an unexpected financial update, as the company dramatically revised its annual revenue...

Beam Therapeutics Inc enters a potentially transformative period this week, with two significant events poised to influence the biotechnology firm's...

Legend Biotech Corp finds itself at a critical juncture, navigating a complex landscape of promising clinical developments against a backdrop...

Market experts are displaying growing confidence in Apogee Therapeutics, with multiple financial institutions either initiating coverage or upgrading their assessments...

The fate of CureVac hangs in the balance as shareholders approach a critical decision point regarding BioNTech's acquisition proposal. With...

The healthcare conglomerate Johnson & Johnson finds itself navigating a complex landscape defined by stellar financial performance on one hand...